|
1
|
Possible antipsychotic effects of minocycline in patients with schizophrenia.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2006
|
1.56
|
|
2
|
Hyperbilirubinemia-related behavioral and neuropathological changes in rats: a possible schizophrenia animal model.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2009
|
1.44
|
|
3
|
Minocycline as adjunctive therapy for schizophrenia: an open-label study.
|
Clin Neuropharmacol
|
2008
|
1.11
|
|
4
|
Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.
|
Clin Neuropharmacol
|
2009
|
1.05
|
|
5
|
Marked improvement in delirium with ramelteon: five case reports.
|
Psychogeriatrics
|
2012
|
0.95
|
|
6
|
Yi-gan san for the treatment of borderline personality disorder: an open-label study.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2007
|
0.92
|
|
7
|
Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2007
|
0.90
|
|
8
|
Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders.
|
Eur Neuropsychopharmacol
|
2005
|
0.88
|
|
9
|
Factors disturbing treatment for cancer in patients with schizophrenia.
|
Psychiatry Clin Neurosci
|
2006
|
0.85
|
|
10
|
NREM sleep stage transitions control ultradian REM sleep rhythm.
|
Sleep
|
2011
|
0.84
|
|
11
|
Successful treatment with Yi-Gan San for psychosis and sleep disturbance in a patient with dementia with Lewy bodies.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2007
|
0.83
|
|
12
|
Increased urinary excretion of biopyrrins, oxidative metabolites of bilirubin, in patients with schizophrenia.
|
Psychiatry Res
|
2007
|
0.81
|
|
13
|
High salivary alpha-amylase levels in patients with schizophrenia: A pilot study.
|
Prog Neuropsychopharmacol Biol Psychiatry
|
2010
|
0.80
|
|
14
|
Fluid-attenuated inversion-recovery MR imaging in schizophrenia-associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).
|
Eur Psychiatry
|
2005
|
0.80
|
|
15
|
Prediction of response within the first 3 days to treatment with paroxetine for depression.
|
Prim Care Companion J Clin Psychiatry
|
2008
|
0.77
|
|
16
|
Influence of sevelamer on mineral metabolism and hyperparathyroidism in Japanese hemodialysis patients.
|
Ther Apher Dial
|
2007
|
0.75
|
|
17
|
Novel Therapy With Ramelteon for Hypoactive Delirium: A Case Report.
|
J Clin Psychopharmacol
|
2015
|
0.75
|